Creatinine Measurement: An Emerging Market with Attractive Growth Opportunities

03.10.2019 - 13:50 | 1759156


Artikel von marketsandmarkets

Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecast to 2023

According to the new market research “Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecast to 2023", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 349.9 Million in 2017, at a CAGR of 8.4%. 

The global Creatinine Measurement market is segmented based on product, test type, sample, end user and regions

The creatinine measurement market, by test type, is segmented into the Jaffe’s kinetic method and enzymatic method. In 2018, the Jaffe’s kinetic method segment is expected to hold the largest share of the creatinine measurement market. The widespread availability and cost-effectiveness of kits and reagents used in Jaffe’s kinetic method is a key factor driving the growth of this market.

Download a PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=206847385

Browse and in-depth TOC on in “Creatinine Measurement Market " 
96 - Tables
21 - Figures 
210 - Pages 

Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to witness the highest CAGR over the forecast period. Most creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples owing to its accuracy in inferring creatinine concentration and low risk of contamination. These benefits are responsible for the increasing adoption of the blood/serum sample for the measurement of creatinine levels.

Based on end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement owing to established infrastructures with an advanced diagnostic assembly for better diagnostic results within shorter time spans. The diagnostic laboratories segment is expected to witness the highest growth over the forecast period as various market players are entering into long-term collaborations with diagnostic laboratories in order to increase their presence in the creatinine measurement market.



Request Free Sample Report (at)
https://www.marketsandmarkets.com/requestsampleNew.asp?id=206847385

In 2018, North America is expected to dominate the market followed by Europe. The large share of North America is attributed to factors such as the increasing incidence of renal disorders, rising prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction) in the region, and the implementation of favorable government initiatives to increase awareness about kidney diseases and their early diagnosis.

Market Players

The key players in the Creatinine Measurement market are F. Hoffmann-la Roche Ltd (Switzerland)., Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific Inc (US), Siemens Healthineers (Germany), Randox Laboratories (UK)., Pointe Scientific, Inc (US), Sentinel Ch. Spa. (Italy), Diasys Diagnostic Systems GmbH (Germany), Dialab GmbH (Vienna), Diazyme Laboratories, Inc (US), Wako Pure Chemical Industries, Ltd. (Japan), Ortho Clinical Diagnostics (US), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

View Complete Press Release (at) 
https://www.marketsandmarkets.com/PressReleases/creatinine-measurement.asp

Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


Leseranfragen:

PresseKontakt / Agentur:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Anmerkungen:

1759156

Kontakt-Informationen:
Vor- / Nachname: marketsandmarkets

Ansprechpartner: Mr. Shelly Singh
Stadt: northbrook
Telefon: 8886006441

Keywords (optional):
creatinine-measurement-market, global-creatinine-measurement-market, creatinine-measurement, creatinine-measurement-market-size, creatinine-measurement-market-forecast, creatinine-measurement-market-share, creatinine-measurement-market-trends, creatinine,

Dieser Artikel wurde bisher 36 mal aufgerufen.

Verlinkung-Tipps:



Direkter Link zu diesem Artikel:




Diese Pressemeldung bookmarken bei...


Tausendreporter BlinkList del.icio.us Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.


Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht internet-intelligenz.de


[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]


Alle Artikel von marketsandmarkets RSS Feed

Mass Spectrometry : Future Forecast Indicates Impressive Growth Rate
Reaction Monitoring Market Trends Estimates High Demand by 2022
Dragonfly Therapeutics startet Phase-I/II-Studie für DF1001 bei Patienten mit fortgeschrittenen soliden Tumoren
Merck lizenziert CRISPR-Technologie zur Genomeditierung an Evotec
18-Mio-Dollar-Investition von AGC Biologics in Seattle und Dänemark stärkt globale Präsenz





Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by TopBlogs.de